Tamir Biotechnology, Inc. (formerly Alfacell Corporation) targeting microRNAs, is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials.
Selskapet beskrivelse:
the product candidate, onconase®, is an rnase that overcomes the challenges of targeting rna for therapeutic purposes while enabling the development of a new class of therapies for cancer, viral, and other life-threatening diseases.
kopiere og lime inn denne google map til din nettside eller blogg!
Trykk på knappen kopiere og lime inn i din blogg eller nettside.
(Du kan bytte til HTML -modus når du legger inn din blogg. Examples: WordPress Example, Blogger Example)